Utah People's Post

The Latest News from the Beehive State

Wednesday, January 20, 2021
Log in
  • National News
    • Female Caseworker Killed & Doctor Shot in Philadelphia
  • State News
    • Car Chase Leads to Drug Arrest
  • Tech & Science
  • Health
    • How to Prepare For Ticks Season
    • Magical Weight Loss Bean Scam
  • Sports
  • Business
You are here: Home / Health / GSK Ebola Vaccine Going into Clinical Trials Soon

GSK Ebola Vaccine Going into Clinical Trials Soon

Posted by

Considering the acute situation in which West Africa finds itself, drug manufacturers now face the situation of having to start clinical trials on experimental drugs. As such, GlaxoSmithKline has announced that it will start the clinical trial for its vaccine against the Ebola virus.

The British drug manufacturer has been developing this vaccine together with U.S. scientists and because of the recent outbreak in western Africa, they now find themselves forced to hasten the process of development so that the disease doesn’t continue to spread uncontrolled. This increased pressure on researchers has indeed accelerated their work and has allowed that experimental serums also be administered to patients who had contracted the Ebola virus.

download (15)

There is currently no proven vaccine or cure against the virus that has killed more than 1,000 people in the countries of West Africa where the outbreak is happening. According to epidemiologists, the disease could spread for months and because of its gravity, the World Health Organization had to declare an international state of health emergency.

In animal studies, the vaccine that GSK has been producing has shown promising results. If the U.S. Food and Drug Administration approves the proceedings, the vaccine will soon enter Phase I of human testing. If all goes well, according to a company spokeswoman, the trial should commence later in 2014 (while the National Institute of Allergy and Infectious Diseases implied that it could happen as early as fall 2014).

In spite of the fast-tracked pace and the emergency situation in which the world finds itself, a vaccine released for widespread deployment couldn’t be ready before 2015. GSK officials haven’t drawn a concrete timeline for the vaccine launch, saying that the vaccine still finds itself at the beginning of its development. They added that it has a long way to go and that possible side effects need to be identified before the vaccine is feely offered to the general population.

The vaccine that GSK has developed is based on a chimpanzee adenovirus in which Ebola genes have been inserted so that the virus enters cells and delivers the Ebola genes so that the body can produce an immune response. What is most important is that the adenovirus that carries the Ebola genes does not replicate in human cells.

Additionally, the vaccine is designed to also offer additional protection against Marburg, a disease from the same family as Ebola, which is also highly contagious and fatal.

Share this:

  • Tweet
  • Share on Tumblr
  • Email

Filed Under: Health, National News Tagged With: clinical trials, Ebola, ebola clinical trials, ebola treatment, ebola vaccine, gsk

Woman working out at the gym

Just 23% of Americans Are Working Out Enough in Their Spare Time

By

Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

By

United Airlines airplane

Passenger Mysteriously Dies on United Airlines flight Bound for Boston

By

Breakfast sandwich

Here Are Some Foods No Nutritionist Would Ever Eat

By

Poppy flower

UN Warns of Surge in Opium-based Drugs and Cocaine Supply

By

U.S.-Canada border

French Jogger Detained 2 Weeks for Accidentally Crossing Border

By

Plus size model

Normalizing Plus Size Could Fuel Obesity Crisis (Study)

By

Giant manta ray

Unique Manta Ray Nursery Spotted off Texas Coast

By

The rainbow flag

WHO Scraps Transgenderism from List of Mental Illnesses

By

456 People Dead at U.K. Hospital after Taking too Many Painkillers

By

Kenyan girls dancing

Kenyans Facing Poor Nutrition as Supermarket Shopping Is on the Rise

By

Pages

  • About
  • Contact
  • Privacy Policy GDPR
  • Staff
  • Terms and Conditions

Recent Posts

  • Just 23% of Americans Are Working Out Enough in Their Spare Time
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)
  • Passenger Mysteriously Dies on United Airlines flight Bound for Boston
  • Here Are Some Foods No Nutritionist Would Ever Eat
  • UN Warns of Surge in Opium-based Drugs and Cocaine Supply
  • French Jogger Detained 2 Weeks for Accidentally Crossing Border
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

Related Articles

  • Woman working out at the gym

    Just 23% of Americans Are Working Out Enough in Their Spare Time

  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

  • Breakfast sandwich

    Here Are Some Foods No Nutritionist Would Ever Eat

  • U.S.-Canada border

    French Jogger Detained 2 Weeks for Accidentally Crossing Border

  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

  • The rainbow flag

    WHO Scraps Transgenderism from List of Mental Illnesses

  • 456 People Dead at U.K. Hospital after Taking too Many Painkillers

  • Billboard on Texas Interstate Kindly Asking Liberals to Leave

  • Young woman affected by depression

    If You Have PTSD You Were Likely Abused as a Child

  • Obese dog on a leash

    Obese Dogs Can Help Us Better Understand How Obesity Works

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Provo
  • Salt Lake News
  • Science
  • Sports
  • State News
  • Tech & Science
  • Technology
  • Uncategorized
  • West Jordan
  • West Valley City
  • World

Copyright © 2021 utahpeoplespost.com

About · Privacy Policy · Terms of Use · Site Map · Contact

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This website uses cookies to ensure you get the best experience on our website. Learn more.